Vincent Bourgeois

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 324 citations · Full text

Medicine, Oncology, Surgery +14

Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases

Jean‐Luc Van Laethem, Vincent Bourgeois, Jasmine Parma et al. · Gastrointestinal Endoscopy · 1998 · 70 citations

Medicine, Pathology, Diagnostic Pathology +13

Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study

Marie Selvy, Bruno Pereira, Nicolas Kerckhove et al. · Journal of Clinical Medicine · 2020 · 69 citations · Full text

Medicine, Oncology, Pharmacology +13

Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis

Capucine Baldini, Anne Escande, Olivier Bouché et al. · Pancreatology · 2016 · 40 citations

Medicine, Oncology, Pharmacotherapy +13

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies

Alessandro Parisi, Blandine Delaunay, Giada Pinterpe et al. · European Journal of Cancer · 2024 · 22 citations · Full text

Medicine, Oncology, Pharmacology +14